The Division of Hematology and Hemostaseology at the Medical University of Vienna is located in the General Hospital of Vienna and is a leading center in Europe.
Our primary goal is to provide all patients with optimal care and offer services at the highest level. Our department also applies the latest standards in diagnostics and therapy as well as emerging concepts in precision medicine and translational research to ensure the best possible care.
Our center is integrated into an excellent scientific environment at the university and in the international scientific community. Thanks to these collaborations, our study groups and experts are able to guarantee access to the latest diagnostic and therapeutic approaches as well as numerous clinical studies. Our department is ISO 9001:2015 certified and is subject to continuous quality control through regular internal and external evaluations and validation projects.
Our department is a leading teaching and training center for M.D. and Ph.D. students, postdocs and other academic staff and is also part of the Comprehensive Cancer Center (CCC) of the Medical University of Vienna and Vienna General Hospital. Our teams are involved in numerous national and international academic networks and clinical study groups, some of which are coordinated by our experts. Members of our center also coordinate and lead a number of national and international research clusters and institutes, including the Ludwig Boltzmann Institute of Hematology and Oncology (Chair: Prof. P. Valent).
Our research groups and specialist physicians: Our research groups and specialists focus on diverse disease models, including congenital and acquired forms of cytopenia, acute and chronic leukemias, Hodgkin's and non-Hodgkin's lymphomas, myelodysplastic and myeloproliferative neoplasms, amyloidosis, multiple myeloma, aplastic anemia and PNH, mastocytosis, eosinophilic disorders, histiocytosis, blood coagulation disorders including hemophilia, as well as venous thrombosis and pulmonary embolism. In addition, our department conducts special scientific programs in the areas of immunotherapy, gene therapy, leukemic stem cells, cell therapies, psycho-oncology, precision medicine and telemedicine.
The overarching goal of our experimental and translational research efforts is to improve the management, therapy, survival and quality of life of patients with malignant and non-malignant blood cell diseases as well as patients with coagulation disorders and thromboembolic diseases.
Univ.-Prof. Dr. med. univ. Peter Valent
Head of the Division
of Hematology and Hemostaseology